文献速递新发突发、热带与寄生虫病

秘鲁伊基托斯社区前瞻性研究中登革热疾病异质性

Heterogeneity of Dengue Illness in Community-Based Prospective Study, Iquitos, Peru.
PubMed 文献 · Emerg Infect Dis · 2020-01-01

该研究在2016-2019年对秘鲁伊基托斯79例登革病毒RNA逆转录PCR阳性者,于急性期每日采集登革热疾病感知反应(IPR)调查数据,以量化包括轻症在内的疾病异质性。多数参与者为轻型门诊病例,但疾病体验、症状持续时间及各症状最高报告强度存在显著异质性;症状强度比症状有无更能预测主要活动改变。

要点

  • 多数登革热参与者为轻型门诊病例,但疾病体验异质性显著。
  • 症状强度较症状有无更能预测登革热所致主要活动改变。
  • IPR调查可捕捉症状强度、持续时间、性质及活动改变的详细数据。

核心结论

  • 登革热疾病体验、症状持续时间及个体症状最高报告强度存在显著异质性,症状强度是主要活动改变的更有价值预测指标。

研究设计与样本

  • 2016-2019年在秘鲁伊基托斯开展社区前瞻性研究,对79例登革病毒RNA逆转录PCR阳性者在急性期每日采集IPR调查数据。

主要发现

  • 多数参与者为轻型门诊疾病,但疾病体验、症状持续时间及个体症状最高报告强度存在显著异质性。
  • 症状强度比单纯症状有无更能预测登革热期间主要活动改变。
  • IPR测量可反映登革热疾病体验中具有临床意义的异质性及其与行为改变的关系。

临床怎么用

  • 在登革热疫苗与治疗试验中可考虑以症状强度等IPR指标作为合适终点,并关注疾病异质性对行为改变的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Measuring heterogeneity of dengue illness is necessary to define suitable endpoints in dengue vaccine and therapeutic trials and will help clarify behavioral responses to illness. To quantify heterogeneity in dengue illness, including milder cases, we developed the Dengue Illness Perceptions Response (IPR) survey, which captured detailed symptom data, including intensity, duration, and character, and change in routine activities caused by illness. During 2016-2019, we collected IPR data daily during the acute phase of illness for 79 persons with a positive reverse transcription PCR result for dengue virus RNA. Most participants had mild ambulatory disease. However, we measured substantial heterogeneity in illness experience, symptom duration, and maximum reported intensity of individual symptoms. Symptom intensity was a more valuable predicter of major activity change during dengue illness than symptom presence or absence alone. These data suggest that the IPR measures clinically useful heterogeneity in dengue illness experience and its relation to altered human behavior.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Elson WH, Reiner RC, Siles C, et al. Heterogeneity of Dengue Illness in Community-Based Prospective Study, Iquitos, Peru. Emerg Infect Dis. 2020. PMID: 32818402. doi:10.3201/eid2609.191472

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。